Answers are grounded in this paper and cite their sources.
Purpose: In Japan, intravenous (IV) midazolam (MDL) is recommended as first-line therapy for pediatric patients with status epilepticus (SE) if venous access is possible. However, few studies have investigated its use in adults/adolescents with SE. This prospective, uncontrolled, open-label study investigated the efficacy and safety of bolus or continuous IV MDL in adults/adolescents with convulsive SE.Methods: Patients aged ≥15 years who satisfied the diagnostic criteria for SE with convulsive seizures lasting ≥5 min were enrolled. Patients first received bolus IV MDL (0.15 mg/kg). If the seizures continued, additional doses (0.1‒0.3 mg/kg) were administered (maximum cumulative dose: 0.6mg/kg). Patients with a high likelihood of recurrent convulsive seizures were subsequently administered continuous IV MDL (0.1 mg/kg/h). The dose was increased until seizure cessation (maximum: 0.4 mg/kg/h) and administration continued for 24 h from seizure cessation. The primary efficacy endpoint was convulsive seizure cessation after bolus IV. Safety endpoints included adverse events (AEs) and adverse drug reactions (ADRs).Results: Twenty-one patients (aged 18.0‒89.0 years) with SE were enrolled. The convulsive seizure cessation rate after bolus IV MDL was 100.0% (21/21 patients), which was statistically significant (P < 0.001) in one-sample testing (binomial distribution). The most common AE/ADR was hypotension (four patients [19.0%]). There were no deaths, serious AEs/ADRs, or AEs/ADRs leading to discontinuation of MDL. Respiratory depression occurred in two patients (9.5%). None of the patients required mechanical ventilation/endotracheal intubation.Discussion: Bolus IV MDL achieved a high seizure cessation rate in patients with convulsive SE, with minimal effects on respiratory or cardiovascular functions and no major safety issues.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: